Entero Therapeutics Net Tangible Assets

The latest net tangible assets for ENTO is $29M as of March 2026. That compares with $56M in the prior-year period — down 49.3% year over year. Investors often review this figure alongside Entero Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ENTO's net tangible assets moved from $56M to $29M — a 49.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Entero Therapeutics's operating scale or balance-sheet position.

A net tangible assets figure of $29M for ENTO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ENTO's net tangible assets ($29M), review year-over-year change from $56M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.